|
|
|
|
|
Riluzole |
|
6-(trifluoromethoxy)-2-benzothiazolamine |
|
1744-22-5 |
|
Riluzole is a drug used to treat amyotrophic lateral sclerosis. It delays the onset of ventilator-dependence or tracheostomy in selected patients and may increase survival by approximately two months. It is marketed by Aventis Pharmaceuticals Inc with the brand name Rilutek.
|
|
Assay:> 98.5% Apprearnace : Write or light yellow crystal |
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|